Aspen Pharmacare shares lifted 4% on Monday, after the company announced it had received approval for its generic injectable semaglutide in Canada.
Related Posts
News24 | FRIDAY BRIEFING | BEE and EE: Criminalise cronyism, focus on the poor
While Black Economic Empowerment (BEE) has successfully deracialised ownership and created a new class of wealthy black South Africans, it has fallen short of meaningfully […]
Bhairavi Sungum to host AGM
Local newsNews The organisation calls on the community to participate in the preservation of arts and culture. The Bhairavi Sungum of Springs will host […]
News24 | Drug paraphernalia found as March and March forces its way into derelict Durban building
Members of the March and March discovered drug paraphernalia inside a partially demolished derelict building on Charlotte Maxeke Street in Durban on Thursday, following a […]